These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 28143890)

  • 21. XPLN is an endogenous inhibitor of mTORC2.
    Khanna N; Fang Y; Yoon MS; Chen J
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):15979-84. PubMed ID: 24043828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of endothelial cell proliferation and vascular assembly through distinct mTORC2 signaling pathways.
    Wang S; Amato KR; Song W; Youngblood V; Lee K; Boothby M; Brantley-Sieders DM; Chen J
    Mol Cell Biol; 2015 Apr; 35(7):1299-313. PubMed ID: 25582201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down regulation of Peroxiredoxin-3 in 3T3-L1 adipocytes leads to oxidation of Rictor in the mammalian-target of rapamycin complex 2 (mTORC2).
    Olson DH; Burrill JS; Kuzmicic J; Hahn WS; Park JM; Kim DH; Bernlohr DA
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1311-1317. PubMed ID: 28986255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR.
    Yin Y; Hua H; Li M; Liu S; Kong Q; Shao T; Wang J; Luo Y; Wang Q; Luo T; Jiang Y
    Cell Res; 2016 Jan; 26(1):46-65. PubMed ID: 26584640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mTOR (mammalian target of rapamycin) kinase maintains integrity of mTOR complex 2.
    Chen CH; Sarbassov dos D
    J Biol Chem; 2011 Nov; 286(46):40386-94. PubMed ID: 21965657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of mTORC2 by association with the ribosome.
    Zinzalla V; Stracka D; Oppliger W; Hall MN
    Cell; 2011 Mar; 144(5):757-68. PubMed ID: 21376236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial Cell mTOR Complex-2 Regulates Sprouting Angiogenesis.
    Farhan MA; Carmine-Simmen K; Lewis JD; Moore RB; Murray AG
    PLoS One; 2015; 10(8):e0135245. PubMed ID: 26295809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystine Induced-mTORC2 Activation through Promoting Sin1 Phosphorylation to Suppress Cancer Cell Ferroptosis.
    Wang G; Chen L; Qin S; Zheng Y; Xia C; Yao J; Wang P; Deng L
    Mol Nutr Food Res; 2022 Dec; 66(23):e2200186. PubMed ID: 36189894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual phosphorylation of Sin1 at T86 and T398 negatively regulates mTORC2 complex integrity and activity.
    Liu P; Guo J; Gan W; Wei W
    Protein Cell; 2014 Mar; 5(3):171-7. PubMed ID: 24481632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crosstalk between mTOR complexes.
    Xie J; Proud CG
    Nat Cell Biol; 2013 Nov; 15(11):1263-5. PubMed ID: 24189516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The GATOR2-mTORC2 axis mediates Sestrin2-induced AKT Ser/Thr kinase activation.
    Kowalsky AH; Namkoong S; Mettetal E; Park HW; Kazyken D; Fingar DC; Lee JH
    J Biol Chem; 2020 Feb; 295(7):1769-1780. PubMed ID: 31915252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mTOR has a developmental stage-specific role in mitochondrial fitness independent of conventional mTORC1 and mTORC2 and the kinase activity.
    Kalim KW; Zhang S; Chen X; Li Y; Yang JQ; Zheng Y; Guo F
    PLoS One; 2017; 12(8):e0183266. PubMed ID: 28813526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The endosomal sorting complex required for transport pathway mediates chemokine receptor CXCR4-promoted lysosomal degradation of the mammalian target of rapamycin antagonist DEPTOR.
    Verma R; Marchese A
    J Biol Chem; 2015 Mar; 290(11):6810-24. PubMed ID: 25605718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic adipocyte phosphoproteome reveals that Akt directly regulates mTORC2.
    Humphrey SJ; Yang G; Yang P; Fazakerley DJ; Stöckli J; Yang JY; James DE
    Cell Metab; 2013 Jun; 17(6):1009-1020. PubMed ID: 23684622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. mTORC2 Balances AKT Activation and eIF2α Serine 51 Phosphorylation to Promote Survival under Stress.
    Tenkerian C; Krishnamoorthy J; Mounir Z; Kazimierczak U; Khoutorsky A; Staschke KA; Kristof AS; Wang S; Hatzoglou M; Koromilas AE
    Mol Cancer Res; 2015 Oct; 13(10):1377-88. PubMed ID: 26130148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The innate immune kinase TBK1 directly increases mTORC2 activity and downstream signaling to Akt.
    Tooley AS; Kazyken D; Bodur C; Gonzalez IE; Fingar DC
    J Biol Chem; 2021 Aug; 297(2):100942. PubMed ID: 34245780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RasGAP Shields Akt from Deactivating Phosphatases in Fibroblast Growth Factor Signaling but Loses This Ability Once Cleaved by Caspase-3.
    Cailliau K; Lescuyer A; Burnol AF; Cuesta-Marbán Á; Widmann C; Browaeys-Poly E
    J Biol Chem; 2015 Aug; 290(32):19653-65. PubMed ID: 26109071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rictor/mTORC2 signaling mediates TGFβ1-induced fibroblast activation and kidney fibrosis.
    Li J; Ren J; Liu X; Jiang L; He W; Yuan W; Yang J; Dai C
    Kidney Int; 2015 Sep; 88(3):515-27. PubMed ID: 25970154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications.
    Fourneaux B; Chaire V; Lucchesi C; Karanian M; Pineau R; Laroche-Clary A; Italiano A
    Oncotarget; 2017 Jan; 8(5):7878-7890. PubMed ID: 28002802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers.
    Morrison Joly M; Hicks DJ; Jones B; Sanchez V; Estrada MV; Young C; Williams M; Rexer BN; Sarbassov dos D; Muller WJ; Brantley-Sieders D; Cook RS
    Cancer Res; 2016 Aug; 76(16):4752-64. PubMed ID: 27197158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.